1152 related articles for article (PubMed ID: 33965601)
1. SARS-CoV-2, hemoglobin and protoporphyrin IX: Interactions and perspectives.
Courrol LC; de Oliveira Silva FR; Masilamani V
Photodiagnosis Photodyn Ther; 2021 Jun; 34():102324. PubMed ID: 33965601
[TBL] [Abstract][Full Text] [Related]
2. Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.
Magnussen A; Reburn C; Perry A; Wood M; Curnow A
Lasers Med Sci; 2022 Mar; 37(2):1155-1166. PubMed ID: 34218351
[TBL] [Abstract][Full Text] [Related]
3. 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges.
Harada Y; Murayama Y; Takamatsu T; Otsuji E; Tanaka H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742921
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.
Ritz R; Scheidle C; Noell S; Roser F; Schenk M; Dietz K; Strauss WS
PLoS One; 2012; 7(12):e51974. PubMed ID: 23251668
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic and Sonodynamic Therapy with Protoporphyrin IX: In Vitro and In Vivo Studies.
Ponce Ayala ET; Alves Dias de Sousa F; Vollet-Filho JD; Rodrigues Garcia M; de Boni L; Salvador Bagnato V; Pratavieira S
Ultrasound Med Biol; 2021 Apr; 47(4):1032-1044. PubMed ID: 33446374
[TBL] [Abstract][Full Text] [Related]
6. Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement.
Yang X; Palasuberniam P; Kraus D; Chen B
Int J Mol Sci; 2015 Oct; 16(10):25865-80. PubMed ID: 26516850
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and photodynamic efficacy of water-soluble protoporphyrin IX homologue with mPEG550.
Basoglu H; Degirmencioglu I; Eyupoglu FC
Photodiagnosis Photodyn Ther; 2021 Dec; 36():102615. PubMed ID: 34740838
[TBL] [Abstract][Full Text] [Related]
8. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells.
Bissonnette R; Zeng H; McLean DI; Korbelik M; Lui H
Photochem Photobiol; 2001 Aug; 74(2):339-45. PubMed ID: 11547574
[TBL] [Abstract][Full Text] [Related]
9. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
[TBL] [Abstract][Full Text] [Related]
10. Phenytoin reduces 5-aminolevulinic acid-induced protoporphyrin IX accumulation in malignant glioma cells.
Hefti M; Albert I; Luginbuehl V
J Neurooncol; 2012 Jul; 108(3):443-50. PubMed ID: 22528787
[TBL] [Abstract][Full Text] [Related]
11. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
Nakanishi T; Ogawa T; Yanagihara C; Tamai I
J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 5-aminolevulinic acid and its hexylester mediated photodynamic action on human hepatoma cells.
Ren QG; Wu SM; Peng Q; Chen JY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Sep; 34(5):650-4. PubMed ID: 12198571
[TBL] [Abstract][Full Text] [Related]
13. Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.
Kanick SC; Davis SC; Zhao Y; Sheehan KL; Hasan T; Maytin EV; Pogue BW; Chapman MS
Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):561-6. PubMed ID: 26480810
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
[TBL] [Abstract][Full Text] [Related]
15. Identification of excimer delayed fluorescence by Protoporphyrin IX: A novel access to local chromophore concentration?
Croizat G; Gregor A; Joniova J; Gerelli E; Wagnières G
J Photochem Photobiol B; 2022 Apr; 229():112408. PubMed ID: 35294918
[TBL] [Abstract][Full Text] [Related]
16. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
Anayo L; Magnussen A; Perry A; Wood M; Curnow A
Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
[TBL] [Abstract][Full Text] [Related]
17. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.
Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J
Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842
[TBL] [Abstract][Full Text] [Related]
18. Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis.
Johansson A; Faber F; Kniebühler G; Stepp H; Sroka R; Egensperger R; Beyer W; Kreth FW
Lasers Surg Med; 2013 Apr; 45(4):225-34. PubMed ID: 23533060
[TBL] [Abstract][Full Text] [Related]
19. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
[TBL] [Abstract][Full Text] [Related]
20. Cell accumulation and antileishmanial effect of exogenous and endogenous protoporphyrin IX after photodynamic treatment.
Mateus JE; Valdivieso W; Hernández IP; Martínez F; Páez E; Escobar P
Biomedica; 2014; 34(4):589-97. PubMed ID: 25504248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
